• Home
  • BREAST CANCER
  • GASTOINTESTINAL CANCERS
    • GASTRIC CANCER
    • COLON CANCER
    • RECTAL CANCER
    • PANCREATIC CANCER
  • GYNAECOLOGICAL CANCERS
    • UTERINE CANCER
    • OVARIAN CANCER
    • CERVICAL CANCER
  • OTHER CANCERS
    • HEAD AND NECK CANCERS
    • SOFT TISSUE SARCOMA
  • BOOK APPOINTMENT
  • More
    • Home
    • BREAST CANCER
    • GASTOINTESTINAL CANCERS
      • GASTRIC CANCER
      • COLON CANCER
      • RECTAL CANCER
      • PANCREATIC CANCER
    • GYNAECOLOGICAL CANCERS
      • UTERINE CANCER
      • OVARIAN CANCER
      • CERVICAL CANCER
    • OTHER CANCERS
      • HEAD AND NECK CANCERS
      • SOFT TISSUE SARCOMA
    • BOOK APPOINTMENT
  • Home
  • BREAST CANCER
  • GASTOINTESTINAL CANCERS
    • GASTRIC CANCER
    • COLON CANCER
    • RECTAL CANCER
    • PANCREATIC CANCER
  • GYNAECOLOGICAL CANCERS
    • UTERINE CANCER
    • OVARIAN CANCER
    • CERVICAL CANCER
  • OTHER CANCERS
    • HEAD AND NECK CANCERS
    • SOFT TISSUE SARCOMA
  • BOOK APPOINTMENT

Dr. RAHUL REDDY LEVAKA

Dr. RAHUL REDDY LEVAKADr. RAHUL REDDY LEVAKADr. RAHUL REDDY LEVAKA

GASTRIC CANCER (CANCER OF THE STOMACH)

Introduction

Epidemiology of Gastric Cancer in India


Gastric cancer is a significant public health concern in India, where it is a common malignancy and a leading cause of cancer-related mortality. The disease tends to present at advanced stages due to late detection, which impacts the overall survival rates.


Incidence and Mortality:

In India, gastric cancer is the fifth most common cancer among men and the sixth among women. According to the National Cancer Registry Programme (NCRP) data for 2020, there were approximately 49,000 new cases of gastric cancer. This translates to an age-standardized incidence rate (ASIR) of about 4.4 per 100,000 population in men and 2.2 per 100,000 in women.


Gastric cancer is a leading cause of cancer deaths in India. In 2020, it was estimated that there were about 34,000 deaths due to gastric cancer, reflecting a high mortality rate. The age-standardized mortality rate (ASMR) is approximately 3.6 per 100,000 for men and 1.8 per 100,000 for women.


Regional Variations:

The incidence of gastric cancer varies across different regions of India. Higher rates are observed in the northeastern states, such as Assam and Manipur, as well as in some parts of northern India. In contrast, the southern states tend to report relatively lower incidence rates.


Risk Factors Specific to India:

- Diet and Nutrition: Traditional dietary practices in India include the consumption of foods high in salt and preservatives like pickles, which are associated with an increased risk of gastric cancer. Additionally, a diet low in fresh fruits and vegetables can contribute to higher cancer risk.

- Helicobacter pylori: High prevalence of Helicobacter pylori infection in the Indian population is a significant risk factor for gastric cancer. This bacterium is linked to chronic gastritis and peptic ulcer disease.

- Tobacco and Alcohol Use: Tobacco chewing and alcohol consumption are prevalent risk factors that contribute to the higher incidence of gastric cancer in India.

- Genetics and Family History: Genetic predispositions and family history of gastric cancer also play a role, though less well-documented compared to environmental and lifestyle factors.


Trends and Survival Rates:

The incidence of gastric cancer in India has been relatively stable in recent years, with some regional variations. Survival rates for gastric cancer in India are lower compared to developed countries, largely due to late-stage diagnosis and limited access to advanced treatment options. The 5-year survival rate for gastric cancer in India is estimated to be around 30%, which is lower than the global average.


Efforts and Initiatives:

In response to the high burden of gastric cancer, several initiatives are underway to improve early detection and treatment. Public health programs aim to increase awareness about the risk factors, promote screening for high-risk individuals, and improve access to healthcare services. Additionally, research into better treatment modalities and preventive measures is ongoing.


Overall, while progress is being made in understanding and combating gastric cancer in India, challenges remain in terms of early detection, treatment access, and public awareness.

Symptoms of Gastric Cancer

Gastric cancer often presents with symptoms that can be subtle or easily mistaken for other gastrointestinal issues, especially in its early stages. As the disease progresses, symptoms may become more pronounced. Here are some common symptoms of gastric cancer:

Early Symptoms

  • Indigestion or Heartburn: Persistent discomfort or burning sensation in the chest or upper abdomen.
  • Nausea and Vomiting: Frequent episodes of nausea, sometimes accompanied by vomiting, which may include blood or material that looks like coffee grounds.
  • Loss of Appetite: A noticeable decrease in appetite, often accompanied by a feeling of fullness after eating only a small amount of food.
  • Bloating: Abdominal bloating or a feeling of fullness, which may be persistent or come and go.

Advanced Symptoms

  • Abdominal Pain: Persistent or severe pain in the upper abdomen, which may be dull or sharp.
  • Difficulty Swallowing (Dysphagia): A sensation that food is getting stuck in the throat or chest.
  • Weight Loss: Unintentional weight loss, which can be significant and noticeable over time.
  • Fatigue and Weakness: General feelings of tiredness and lack of energy, which can be due to the cancer itself or related to anemia.

Other Symptoms

  • Dark or Black Stools: This can indicate bleeding in the stomach, which may lead to black, tarry stools.
  • Jaundice: Yellowing of the skin and eyes, which can occur if the cancer spreads to the liver and affects its function.
  • Swelling in the Abdomen: Accumulation of fluid in the abdominal cavity, known as ascites, which can cause swelling and discomfort.
  • Persistent Cough or Hoarseness: If the cancer has spread to the lungs or nearby structures, it can cause coughing or a hoarse voice.

Systemic Symptoms

  • Anemia: Low red blood cell count, leading to symptoms like paleness, shortness of breath, and dizziness.
  • Persistent Fever: Unexplained fever that doesn’t resolve with usual treatments.

Diagnostic Testing for Gastric Cancer


Upper Endoscopy (Gastroscopy):

  • What It Is: A procedure where a thin, flexible tube with a camera (endoscope) is inserted through the mouth to look inside the stomach.
  • Purpose: To see the inside of the stomach, check for abnormal areas, and take a small tissue sample (biopsy) if needed.

Biopsy:

  • What It Is: A small sample of tissue taken from the stomach during an endoscopy.
  • Purpose: To check under a microscope if the cells are cancerous and determine the type of cancer.


Endoscopic Ultrasound (EUS):

  • What It Is: A special endoscope with an ultrasound probe is used to create detailed images of the stomach and surrounding tissues.
  • Purpose: To see how deep the cancer has grown into the stomach wall and if it has spread to nearby lymph nodes.


Abdominal Ultrasound:

  • What It Is: An imaging test that uses sound waves to create images of the organs in the abdomen.
  • Purpose: To check if the cancer has spread to the liver or other organs.


CT Scan (Computed Tomography):

  • What It Is: An imaging test that takes detailed cross-sectional pictures of the body using X-rays.
  • Purpose: To see if the cancer has spread to other parts of the body, like the liver, lungs, or lymph nodes.


MRI (Magnetic Resonance Imaging):

  • What It Is: An imaging test that uses strong magnets and radio waves to create detailed images of the inside of the body.
  • Purpose: To get detailed images, especially useful if a CT scan isn’t clear or if there's a concern about the liver.


Blood Tests:

  • What They Are: Tests that check various aspects of your blood.
  • Purpose: To look for signs of anemia (low red blood cells), liver function, and sometimes specific substances that may be elevated with cancer

Management Of Gastric Cancer

Surgery

Surgery is a primary treatment for gastric cancer, aiming to remove the tumor and any affected surrounding tissues. The approach depends on the cancer's stage and location, with options ranging from partial to total gastrectomy. Effective surgical treatment often involves lymph node dissection to ensure comprehensive removal of cancerous cells and improve patient outcomes.



1. Total Gastrectomy:

  • Description: Complete removal of the entire stomach.
  • Procedure: The entire stomach is removed along with adjacent lymph nodes. The esophagus is then connected directly to the small intestine.
  • Lymph Node Dissection:
    • D1 Lymph Node Dissection: Removes only the lymph nodes immediately around the stomach.
    • D2 Lymph Node Dissection: Removes more extensive lymph nodes, including those around the stomach, spleen, and liver, and is often performed in cases with a higher risk of lymph node involvement.
  • Recovery: Requires significant dietary adjustments and lifelong changes. Patients need to eat smaller, more frequent meals and may require nutritional supplements.


2. Partial Gastrectomy (Subtotal Gastrectomy):

  • Description: Removal of only the part of the stomach affected by cancer.
  • Procedure: The cancerous segment of the stomach is removed, and the remaining portion is reconnected to the small intestine.
  • Lymph Node Dissection:
    • D1 Lymph Node Dissection: Includes removal of lymph nodes near the removed part of the stomach.
    • D2 Lymph Node Dissection: May be performed if the cancer is more advanced, involving a wider range of lymph nodes including those around the stomach and nearby organs.
  • Recovery: Involves fewer changes compared to total gastrectomy but still requires dietary adaptation.


3. Laparoscopic Surgery (Minimally Invasive Surgery):

  • Description: Performed through small incisions using a laparoscope.
  • Procedure: The surgeon uses a laparoscope and specialized instruments to remove the cancerous tissue and may perform a partial or total gastrectomy.
  • Lymph Node Dissection:
    • D1 Lymph Node Dissection: Similar to open surgery, removes lymph nodes around the stomach.
    • D2 Lymph Node Dissection: More extensive, depending on the extent of the cancer.
  • Recovery: Typically involves less pain and quicker recovery compared to traditional open surgery.


4. Palliative Surgery:

  • Description: Focuses on relieving symptoms rather than curing cancer.
  • Types of Procedures:
    • Stent Placement: To relieve blockages.
    • Bypass Surgery: To create a new pathway around a blocked area.
  • Lymph Node Dissection: Often limited or not performed as the goal is symptom relief rather than cancer removal.
  • Recovery: Focuses on improving quality of life and managing symptoms.


Lymph Node Dissection Types Explained:

  • D1 Lymph Node Dissection: Involves the removal of lymph nodes directly around the stomach and the first level of lymph nodes that drain from the stomach. It is often used for early-stage cancers.
  • D2 Lymph Node Dissection: A more extensive procedure that includes the removal of lymph nodes beyond the immediate area around the stomach, including those near the liver, pancreas, and spleen. This approach is generally used for more advanced cancers to ensure a broader range of potential cancer spread is addressed.

Chemotherapy 


chemotherapy is a systemic approach that uses cytotoxic agents to target and destroy cancer cells throughout the body. It can be administered before surgery (neoadjuvant) to shrink tumors, after surgery (adjuvant) to eliminate remaining cancer cells, or for advanced stages (palliative) to manage symptoms and slow disease progression. Chemotherapy can be delivered intravenously in a clinical setting or orally in pill form.


Radiation Therapy 


radiation therapy utilizes high-energy radiation to damage the DNA of cancer cells, leading to their destruction. This therapy may be used preoperatively in conjunction with chemotherapy to reduce tumor size, postoperatively to target any residual cancer cells at the surgical site, or palliatively to relieve symptoms like pain, bleeding, or obstruction. The radiation is delivered externally from a machine focused on the tumor area.


Targeted Therapy focuses on specific molecular pathways or genetic alterations within cancer cells. This can include targeting receptors overexpressed in some gastric cancers or inhibiting the formation of blood vessels necessary for tumor growth. The therapy employs monoclonal antibodies or tyrosine kinase inhibitors to interfere with cancer cell proliferation.


Immunotherapy enhances the immune system’s ability to recognize and attack cancer cells. It is particularly useful for advanced gastric cancer with high microsatellite instability (MSI-H) or specific immune checkpoint markers. This approach includes checkpoint inhibitors that boost the immune response by blocking proteins that normally inhibit immune activity against cancer cells.


Supportive (Palliative) Care is aimed at improving the quality of life by managing symptoms and providing comprehensive support. This includes pain management strategies, nutritional support to address issues such as malnutrition and feeding difficulties, psychosocial support through counseling and social services, and overall symptom management to enhance comfort and functional status


Copyright © 2025 Dr. RAHUL REDDY LEVAKA - All Rights Reserved.

  • BOOK APPOINTMENT

Powered by GoDaddy

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept